13F

Stock

Acadia Pharmaceuticals Inc

ACAD · held by 7 managers

Reported value

$12.5M

Holders

7

+2 new · −0 exited

Holders’ est. mark

$1.78M

Price effect on 4 books still in the name

Largest holder

$9.22M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC427.5K$9.22M$1.23MAdded$5.09M
DANSKE BANK A/S65.4K$1.41M$324.6KAdded$83.8K
VIRTUS ADVISERS, LLC43K$926.9K$213.2KAdded$213.2K
OP Asset Management Ltd39.1K$844.3KNew
Leonteq Securities AG2.35K$50.7K$11.4KAdded$12.6K
Essential Partners LLC576$12.4KHeld
ELEVATION POINT WEALTH PARTNERS, LLC16$345New

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.